68 -- CONSTRUCTION OF A RECOMBINANT ADENOVIRUS

Notice Date

September 19, 2000

Contracting Office

Acquisitions Management Operations Branch, NIAID, 6700-B Rockledge Drive, Room 1130, Bethesda, MD 20892-7605

ZIP Code

20892-7605

Solicitation Number

NOI0022

Response Due

September 28, 2000

Point of Contact

Charmaine Rawlinson, Purchasing Agent (301) 594-3420/Rebecca A. Guenthner, Contracting Officer (301) 402-2284

Description

This is a combined synopsis/solicitation Notice of Intent for production of recombinant adenoviruses. It includes production of recombinant adenoviruses from The National Institute of Allergy and Infectious Diseases supplied DNA vectors, and plaque purification of the resultant viruses and screening for gene product incorporation. This announcement constitutes the only solicitation; quotes are not being requested and a written solicitation will not be issued. The solicitation number is issued as a Notice of Intent (NOI0022). The solicitation document and incorporated provisions are those in effect through Appropriate Federal Acquisitions Circulars #18. The NIAID intends to award to Quantum Biotechnologies. Quantum Biotechnologies, Inc produced the previous set of recombinant adenoviruses and to make a valid scientific comparison between the different stocks they must be produced using the same DNA vectors and from the same virus pools. Using another virus stock could skew the immune response and the immunodominance hierarchy. This acquisition is being conducted as a Small business set-aside. The SIC code is 3826; the business size is 500 employees The National Institutes of Allergy and Infectious Diseases intends to procure production of recombinant adenovirus & amplification of specific recombinant adenovirus clones in 293 cells. Delivery shall be to the National Institutes of Health, 9000 Rockville Pike, Bethesda, Maryland, 20892, F.O.B. destination. The clause at 52.212-1, Instructions to Offerors applies to this acquisition and clause 52.212-3, Offeror Representations and Certifications. The clause at 52.212-4, Contract Terms and Conditions-Commercial Items applies to this acquisition. The government will award a fixed price purchase order to Quantum Biotechnologies, Inc. The clause at 52-212-5, Contract Terms and Conditions Required to Implement Statues or Executive Orders-Commercial Items applies to this acquisition. The clauses of subpart (b), which apply, are: 6 and 10. Any response is due no later than 3:00 p.m. eastern daylight savings time, September 28, 2000 to Charmaine Rawlinson. For delivery through the postal service the address is: 6700B Rockledge Drive, MSC 7605, Room 1130, Bethesda, MD 20892-7605. Electronic submission will not be accepted. Request for any information concerning this requirement is to be referred to Ms. Charmaine Rawlinson, 301-496-2607. Collect calls will not be accepted.

Record

Loren Data Corp. 20000921/68SOL005.HTM (W-263 SN498341)